Down regulation of human natural killer cell-mediated cytolysis induced by blood transfusion: Role of transforming growth factor-β1, soluble Fas ligand, and soluble Class i human leukocyte antigen

Transfusion

Volumn 51, Issue 7, 2011, Pages 1567-1573

  Ghio, Massimo ^a,b,c   Contini, Paola ^a,b,c   Negrini, Simone ^a,b,c   Mazzei, Clemente ^a,b,c   Zocchi, Maria R ^a,b,c   Poggi, Alessandro ^a,b,c  

^a UNIVERSITY OF GENOA   (Italy)

^b Blood Bank of Ospedali Civili Imperia   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; FAS LIGAND; LEUKOCYTE ANTIGEN; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR NKG2D; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BLOOD TRANSFUSION; CELL ACTIVATION; CYTOLYSIS; CYTOTOXICITY; DOWN REGULATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOKINE ACTIVATED KILLER CELL; NATURAL KILLER CELL;

BLOOD TRANSFUSION; CYTOTOXICITY, IMMUNOLOGIC; DOWN-REGULATION; FAS LIGAND PROTEIN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, LYMPHOKINE-ACTIVATED; KILLER CELLS, NATURAL; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 79960184745     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.03000.x     Document Type: Article

References (23)

1. Vamvakas EC, Blajchman MA,. Transfusion-related immunomodulation (TRIM): an update. Blood Rev 2007; 21: 327-48. (Pubitemid 47498679)
2. Blumberg N, Heal JM,. Immunomodulation by blood transfusions: an evolving scientific and clinical challenge. Am J Med 1996; 101: 299-308. (Pubitemid 26392443)
3. Blajchman MA,. Allogeneic blood transfusions, immunomodulation, and postoperative bacterial infection: do we have the answers yet? Transfusion 1997; 37: 121-5.
4. Houbiers JG, van de Velde CJ, van de Watering LM, Hermans J, Schreuder S, Bijnen AB, Pahlplatz P, Schattenkerk ME, Wobbes T, de Vries JE, Klementschitsch P, van de Maas AH, Brand A,. Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: a prospective study. Transfusion 1997; 37: 126-34. (Pubitemid 27091896)
5. Vamvakas EC, Moore SB,. Blood transfusion and postoperative septic complications. Transfusion 1994; 34: 714-27. (Pubitemid 24270119)
6. Trinchieri G,. Biology of natural killer cells. Adv Immunol 1989; 47: 187-376. (Pubitemid 20010960)
7. Long EO,. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol 1999; 17: 875-904. (Pubitemid 29241142)
8. Lanier LL,. NK cell receptors. Annu Rev Immunol 1998; 16: 359-93. (Pubitemid 28183369)
9. Spaggiari GM, Carosio R, Pende D, Marcenaro S, Rivera P, Zocchi MR, Moretta L, Poggi A,. NK cell-mediated lysis of autologous antigen-presenting cells is triggered by the engagement of the phosphatidylinositol 3-kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46. Eur J Immunol 2001; 31: 1656-65. (Pubitemid 32547327)
10. Moretta A, Bottino C, Vitale M, Pende D, Biassoni R, Mingari MC, Moretta L,. Receptors for HLA-class I molecules in human natural killer cells. Annu Rev Immunol 1996; 14: 619-48. (Pubitemid 26130196)
11. Ghio M, Contini P, Negrini S, Boero S, Musso A, Poggi A,. Soluble HLA-I-mediated secretion of TGF-beta1 by human NK cells and consequent down-regulation of anti-tumor cytolytic activity. Eur J Immunol 2009; 39: 3459-68.
12. Ghio M, Contini P, Mazzei C, Brenci S, Barberis G, Filaci G, Indiveri F, Puppo F,. Soluble HLA Class I, HLA Class II, and Fas ligand in blood components: a possible key to explain the immunomodulatory effects of allogeneic blood transfusions. Blood 1999; 93: 1770-7. (Pubitemid 29102506)
13. Ghio M, Contini P, Mazzei C, Brenci S, Barberis G, Filaci G, Indiveri F, Puppo F,. In vitro immunosuppressive activity of soluble HLA class I and Fas ligand molecules: do they play a role in autologous blood transfusion? Transfusion 2001; 41: 988-96. (Pubitemid 33642787)
14. Zocchi MR, Contini P, Alfano M, Poggi A,. Pertussis toxin (PTX) B subunit and the non-toxic PTX mutant PT9K/129G inhibit TAT-induced TGF-β production by NK cells and TGF-β-mediated NK cell apoptosis. J Immunol 2005; 174: 6054-61. (Pubitemid 40663793)
15. Poggi A, Carosio R, Fenoglio D, Brenci S, Murdaca G, Setti M, Indiveri F, Scabini S, Ferrero E, Zocchi MR,. Migration of Vdelta1 and Vdelta2 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1-infected patients: competition by HIV-1 Tat. Blood 1999; 103: 2205-13. (Pubitemid 38326239)
16. Poggi A, Prevosto C, Massaro AM, Negrini S, Urbani S, Pierri I, Saccardi R, Gobbi M, Zocchi MR,. Interaction between human natural killer cells and bone marrow stromal cells induces NK cell triggering. Role of NKp30 and NKG2D receptors. J Immunol 2005; 175: 6352-60. (Pubitemid 41598875)
17. Poggi A, Massaro AM, Negrini S, Contini P, Zocchi MR,. Tumour-induced apoptosis of human IL2-activated natural killer cells. Role of natural cytotoxicity receptors. J Immunol 2005; 174: 2653-60. (Pubitemid 40279679)
18. Spaggiari GM, Contini P, Negrini S, Dondero A, Carosio R, Ghio M, Puppo F, Indiveri F, Zocchi MR, Poggi A,. IFN-gamma production in human NK cells through the engagement of CD8 by soluble or surface HLA class I molecules. Eur J Immunol 2003; 33: 3049-59. (Pubitemid 37428337)
19. Groh V, Wu J, Yee C, Spies T,. Tumor-derived soluble MIC ligands impair expression of NKG2D and T cell activation. Nature 2002; 419: 734-8. (Pubitemid 35177960)
20. Spaggiari GM, Contini P, Carosio R, Arvigo M, Ghio M, Oddone D, Dondero A, Zocchi MR, Puppo F, Indiveri F, Poggi A,. Soluble HLA class I molecules induce natural killer cell apoptosis through the engagement of CD8. Evidence for a negative regulation exerted by CD94/NKG2A complex and KIR2D. Blood 2002; 99: 1706-14. (Pubitemid 34533045)
21. Spaggiari GM, Contini P, Dondero A, Carosio R, Puppo F, Indiveri F, Zocchi MR, Poggi A,. Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interaction. Blood 2002; 100: 4098-107. (Pubitemid 35396878)
22. Ottonello L, Ghio M, Contini P, Bertolotto M, Bianchi G, Montecucco F, Colonna M, Mazzei C, Dallegri F, Indiveri F,. Nonleukoreduced red blood cell transfusion induces a sustained inhibition of neutrophil chemotaxis by stimulating in vivo production of transforming growth factor-beta1 by neutrophils: role of the immunoglobulinlike transcript 1, sFasL and sHLA-I. Transfusion 2007; 47: 1395-404. (Pubitemid 47101062)
23. Puppo F, Contini P, Ghio M, Brenci C, Scudelletti M, Filaci G, Ferrone S, Indiveri F,. Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8+ Fas (CD95)+ T lymphocytes. Int Immunol 2000; 12: 195-203. (Pubitemid 30088312)